Explore
Indications
Compare disease-area coverage and open the matching records.
44/46Covered
29Active
21Marketed
34%Strong Evidence
Indication Readiness Table
Ranked by record coverage and active signal.
| Indication | Signals | Evidence | Type Mix | Lead Modality | Lead Organization |
|---|---|---|---|---|---|
| Hearing Loss 391 linked records across 138 organizations | 128strong evidence80active171marketed | 33%strong evidence | Therapeutic + Device | Small Molecule | Institution-led study |
| Sensorineural Hearing Loss 236 linked records across 87 organizations | 96strong evidence51active106marketed | 41%strong evidence | Therapeutic + Device | Hearing Aid/Software | Institution-led study |
| Tinnitus 104 linked records across 44 organizations | 14strong evidence21active18marketed | 13%strong evidence | Therapeutic + Software/Neurotech | Small Molecule | Institution-led study |
| Age-Related Hearing Loss 86 linked records across 44 organizations | 51strong evidence9active60marketed | 59%strong evidence | Device + Software/Neurotech | Hearing Aid/Software | Institution-led study |
| Sudden Sensorineural Hearing Loss 31 linked records across 11 organizations | 3strong evidence14active0marketed | 10%strong evidence | Therapeutic + Procedure/Rehab | Steroid/Anti-inflammatory | Institution-led study |
| Genetic Hearing Loss 27 linked records across 9 organizations | 4strong evidence7active1marketed | 15%strong evidence | Therapeutic + Diagnostic | Gene Therapy | Institution-led study |
| Conductive Hearing Loss 27 linked records across 12 organizations | 9strong evidence4active19marketed | 33%strong evidence | Device + Diagnostic | Bone Conduction / Middle-Ear Device | Cochlear |
| Cisplatin-Induced Hearing Loss 23 linked records across 10 organizations | 4strong evidence9active2marketed | 17%strong evidence | Therapeutic + Diagnostic | Small Molecule | Institution-led study |
| Communication Impairment 23 linked records across 22 organizations | 10strong evidence9active14marketed | 43%strong evidence | Software/Neurotech + Procedure/Rehab | BCI/Neurotech | Microsoft |
| Noise-Induced Hearing Loss 23 linked records across 12 organizations | 2strong evidence6active2marketed | 9%strong evidence | Therapeutic + Diagnostic | Small Molecule | Institution-led study |
| Mixed Hearing Loss 22 linked records across 10 organizations | 11strong evidence1active19marketed | 50%strong evidence | Device | Bone Conduction / Middle-Ear Device | Cochlear |
| Cochlear Implant 17 linked records across 6 organizations | 14strong evidence0active16marketed | 82%strong evidence | Device + Procedure/Rehab | Cochlear/Auditory Implant | Cochlear |
| Auditory Neuropathy 16 linked records across 15 organizations | 8strong evidence6active9marketed | 50%strong evidence | Diagnostic + Therapeutic | Diagnostic | Interacoustics |
| Sudden Hearing Loss 12 linked records across 4 organizations | 0strong evidence5active0marketed | 0%strong evidence | Therapeutic + Procedure/Rehab | Small Molecule | Institution-led study |
| Single-Sided Deafness 12 linked records across 7 organizations | 6strong evidence1active9marketed | 50%strong evidence | Device + Software/Neurotech | Bone Conduction / Middle-Ear Device | Cochlear |
| Ototoxicity 11 linked records across 3 organizations | 0strong evidence7active0marketed | 0%strong evidence | Therapeutic + Diagnostic | Small Molecule | Institution-led study |
| Speech Impairment 9 linked records across 9 organizations | 4strong evidence5active4marketed | 44%strong evidence | Software/Neurotech + Procedure/Rehab | BCI/Neurotech | Blackrock Neurotech |
| Severe Paralysis 8 linked records across 8 organizations | 3strong evidence7active1marketed | 38%strong evidence | Software/Neurotech | BCI/Neurotech | Blackrock Neurotech |
| Deafness 7 linked records across 6 organizations | 3strong evidence1active3marketed | 43%strong evidence | Software/Neurotech + Device | AI Audio/Speech Accessibility Software | Institution-led study |
| Vestibular Disorders 7 linked records across 3 organizations | 1strong evidence1active1marketed | 14%strong evidence | Diagnostic + Therapeutic | Balance/Posturography Assessment | Institution-led study |
| OTOF-Related Hearing Loss 5 linked records across 5 organizations | 3strong evidence4active1marketed | 60%strong evidence | Therapeutic | Gene Therapy | Eli Lilly and Company |
| Hidden Hearing Loss 5 linked records across 5 organizations | 1strong evidence2active0marketed | 20%strong evidence | Therapeutic + Software/Neurotech | Small Molecule | Cilcare SAS |
| Meniere Disease 5 linked records across 3 organizations | 0strong evidence2active0marketed | 0%strong evidence | Therapeutic + Procedure/Rehab | Steroid/Anti-inflammatory | Institution-led study |
| Cochlear Synaptopathy 4 linked records across 4 organizations | 2strong evidence2active0marketed | 50%strong evidence | Therapeutic | Biologic | Cilcare SAS |
| Congenital Hearing Loss 4 linked records across 4 organizations | 2strong evidence1active3marketed | 50%strong evidence | Device + Software/Neurotech | Prescription Hearing Aid | Institution-led study |
| ALS 3 linked records across 3 organizations | 1strong evidence3active0marketed | 33%strong evidence | Software/Neurotech | BCI/Neurotech | Neuralink |
| Locked-In Syndrome 2 linked records across 2 organizations | 0strong evidence2active0marketed | 0%strong evidence | Software/Neurotech | BCI/Neurotech | BrainGate Consortium |
| Autoimmune Inner Ear Disease 2 linked records across 2 organizations | 0strong evidence0active0marketed | 0%strong evidence | Therapeutic | Biologic | Institution-led study |
| Cerumen Impaction 2 linked records across 2 organizations | 1strong evidence0active1marketed | 50%strong evidence | Diagnostic + Therapeutic | Diagnostic | Institution-led study |
| Meniere Disease 2 linked records across 1 organizations | 0strong evidence0active0marketed | 0%strong evidence | Diagnostic + Procedure/Rehab | Clinical Assessment/Endpoint | Institution-led study |
| Syndromic Hearing Loss 2 linked records across 1 organizations | 0strong evidence0active0marketed | 0%strong evidence | Therapeutic | Small Molecule | Institution-led study |
| Vestibular Testing 2 linked records across 2 organizations | 1strong evidence0active1marketed | 50%strong evidence | Diagnostic | Diagnostic | Institution-led study |
| Aminoglycoside-Induced Hearing Loss 1 linked records across 1 organizations | 0strong evidence1active0marketed | 0%strong evidence | Therapeutic | Small Molecule | Investigator-led study |
| Congenital CMV-Associated Hearing Loss 1 linked records across 1 organizations | 0strong evidence1active0marketed | 0%strong evidence | Therapeutic | Small Molecule | Multiple non-industry cCMV hearing-loss study sponsors |
| Vestibular Schwannoma 1 linked records across 1 organizations | 1strong evidence1active0marketed | 100%strong evidence | Therapeutic | Gene Therapy | Eli Lilly and Company |
| Acquired Hearing Loss 1 linked records across 1 organizations | 0strong evidence0active0marketed | 0%strong evidence | Therapeutic | Cell Therapy | Investigator-led study |
| Cholesteatoma 1 linked records across 1 organizations | 0strong evidence0active0marketed | 0%strong evidence | Diagnostic | Diagnostic | Institution-led study |
| DFNB9 1 linked records across 1 organizations | 0strong evidence0active0marketed | 0%strong evidence | Therapeutic | Gene Therapy | OtoVia Therapeutics |
| Head and Neck Imaging 1 linked records across 1 organizations | 0strong evidence0active0marketed | 0%strong evidence | Diagnostic | Diagnostic | Institution-led study |
| Maternally Inherited Diabetes and Deafness 1 linked records across 1 organizations | 0strong evidence0active0marketed | 0%strong evidence | Therapeutic | Small Molecule | Khondrion BV |
| Mitochondrial Disease 1 linked records across 1 organizations | 0strong evidence0active0marketed | 0%strong evidence | Therapeutic | Small Molecule | Khondrion BV |
| Post-COVID Tinnitus 1 linked records across 1 organizations | 0strong evidence0active0marketed | 0%strong evidence | Therapeutic | Small Molecule | Applied Biology, Inc. |
| Unilateral Hearing Loss 1 linked records across 1 organizations | 0strong evidence0active0marketed | 0%strong evidence | Software/Neurotech | Hearing Aid/Software | Sonova AG |
| Wolfram Syndrome 1 linked records across 1 organizations | 0strong evidence0active0marketed | 0%strong evidence | Therapeutic | Small Molecule | Institution-led study |